Teijin Articles
Astellas and Ambrx collaborate in up to $300 oncology deal; Teijin takes stake in Kyorin
5 April 2013
Teijin debuts Ipsen's Somatuline in Japan; Galenica deal for Maltofer and Uro-Vaxom in China
18 January 2013
Teijin and Ipsen's Somatuline cleared in Japan
1 July 2012
Menarini extends febuxostat accord to more regions
12 April 2012
NovAliX in drug discovery collaboration with Teijin Pharma
13 January 2012
Japan approves Genzyme’s Synvisc for osteoarthritis of the knee and grants reimbursement
21 September 2010
Showing 1-8 of 8 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
